John P Mandeli, PhD
img_John P Mandeli
ASSOCIATE PROFESSOR | Environmental Medicine

My research interests focus on both statistical theory and applications.

A major area of interest is the combinatorial construction of new experimental designs. Specifically, work is being done on the mathematical construction of sets of mutually orthogonal frequency rectangle designs, which are generalizations of latin square designs. In addition, work is underway on the construction of asymmetrical orthogonal arrays, an area of discrete mathematics that plays a fundamental role in fractional factorial experimental designs.

I am also working on the statistical design and analysis of cancer clinical trials. Emphasis is on the proper design and analysis of Phase I and Phase II clinical trials, as well as laboratory studies; and the application of stopping rules, multistage designs, and classical experimental design theory to cancer clinical and laboratory study design.

PhD, Cornell University

Publications

Selected Publications

PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting. Mansi Saxena, Thomas U. Marron, Julia Kodysh, John P. Finnigan, Sayali Onkar, Anna Kaminska, Kevin Tuballes, Ruiwei Guo, Rachel Lubong Sabado, Marcia Meseck, Timothy J. O’donnell, Robert P. Sebra, Samir Parekh, Matthew D. Galsky, Ana Blasquez, Gustavo Gimenez, Mesude Bicak, Cansu Cimen Bozkus, Daniela Delbeau-Zagelbaum, Denise Rodriguez, Ana Acuna-Villaorduna, Krzysztof J. Misiukiewicz, Marshall R. Posner, Brett A. Miles, Hanna Y. Irie, Amy Tiersten, Deborah B. Doroshow, Andrea Wolf, John Mandeli, Rachel Brody, Andres M. Salazar, Sacha Gnjatic, Jeff Hammerbacher, Eric Schadt, Philip Friedlander, Alexander Rubinsteyn, Nina Bhardwaj. Cancer Discovery

A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma. Daniel Chiu, Jingjing Qi, Tin Htwe Thin, Monica Garcia-Barros, Brian Lee, Mary Hahn, John Mandeli, Puneet Belani, Kambiz Nael, Omid Rashidipour, Saadi Ghatan, Constantinos G. Hadjipanayis, Raymund L. Yong, Isabelle M. Germano, Rachel Brody, Nadejda M. Tsankova, Sacha Gnjatic, Seunghee Kim-Schulze, Adília Hormigo. Cancer Research Communications

Quality Care in Survivorship: Lessons Learned from the ASCO Quality Oncology Practice Initiative. Charles L. Shapiro, Nicole Zubizarreta, Erin Moshier, Julia P. Brockway, John Mandeli, Merry Jennifer Markham, Mary May Kozlik, Stephanie Crist, Paul B. Jacobsen. JCO Oncology Practice

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Mandeli has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.